Literature DB >> 29453640

Effect of semi-rapid maxillary expansion in children with obstructive sleep apnea syndrome: 5-month follow-up study.

Saimir Hoxha1, Ecem Kaya-Sezginer2, Filiz Bakar-Ates3, Oğuz Köktürk4, Ufuk Toygar-Memikoğlu1.   

Abstract

BACKGROUND: The purpose of this study was to investigate the effect of semi-rapid maxillary expansion (SRME) orthodontic treatment on biomarkers and respiratory parameters in children with obstructive sleep apnea syndrome (OSAS) and maxillary transverse deficiency.
METHODS: Thirty children with OSAS were included in this study. Fifteen children were enrolled as control, and 15 children were subjected to SRME orthodontic treatment method for 5 months. Beside respiratory parameters, pharyngeal area, dental arch, and postero-anterior widths and the levels of OSAS biomarkers in serum and urine were measured.
RESULTS: Pharyngeal airway space, dental arch, and postero-anterior widths were increased after SRME treatment. Sleep tests showed a decrease in the apnea-hypopnea index (AHI) after 5-month control/treatment duration. Serum kallikrein (KLK)1 levels decreased significantly in the treatment group. There was a significant increase in serum orosomucoid (ORM)2 levels and a decrease in urine perlecan levels in the control group after a 5-month follow-up. A significant negative correlation between serum ORM2, perlecan, gelsolin, and KLK1 levels and intercanin width, as well as between serum ORM2 and KLK1 levels and intermolar width, was observed.
CONCLUSIONS: SRME treatment can be considered as a useful approach in children with OSAS. A further investigation of OSAS-related biomarkers and their relationship with sleep and orthodontic parameters is needed for providing easier and reliable modulatory strategies in the treatment of OSAS.

Entities:  

Keywords:  Obstructive sleep apnea syndrome; Proteins; Semi-rapid maxillary expansion; Sleep test; Uric acid

Mesh:

Substances:

Year:  2018        PMID: 29453640     DOI: 10.1007/s11325-018-1636-4

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  40 in total

1.  Weight loss and sleep-disordered breathing in childhood obesity: effects on inflammation and uric acid.

Authors:  Kim Van Hoorenbeeck; Hilde Franckx; Patrick Debode; Petra Aerts; Kristien Wouters; Jose Ramet; Luc F Van Gaal; Kristine N Desager; Wilfried A De Backer; Stijn L Verhulst
Journal:  Obesity (Silver Spring)       Date:  2011-09-22       Impact factor: 5.002

2.  Rapid maxillary expansion outcomes in treatment of obstructive sleep apnea in children.

Authors:  Maria Pia Villa; Alessandra Rizzoli; Jole Rabasco; Ottavio Vitelli; Nicoletta Pietropaoli; Manuela Cecili; Alessandra Marino; Caterina Malagola
Journal:  Sleep Med       Date:  2015-03-16       Impact factor: 3.492

3.  Control of cytoplasmic actin gel-sol transformation by gelsolin, a calcium-dependent regulatory protein.

Authors:  H L Yin; T P Stossel
Journal:  Nature       Date:  1979-10-18       Impact factor: 49.962

4.  Serum adipocyte-fatty acid binding protein level is elevated in severe OSA and correlates with insulin resistance.

Authors:  D C-L Lam; A Xu; K S-L Lam; B Lam; J C-M Lam; M M-S Lui; M S-M Ip
Journal:  Eur Respir J       Date:  2009-02       Impact factor: 16.671

5.  Gelsolin expression is necessary for the development of modelled pulmonary inflammation and fibrosis.

Authors:  N Oikonomou; A Thanasopoulou; A Tzouvelekis; V Harokopos; T Paparountas; I Nikitopoulou; W Witke; A Karameris; A Kotanidou; D Bouros; V Aidinis
Journal:  Thorax       Date:  2009-02-12       Impact factor: 9.139

6.  Polysomnography in patients with obstructive sleep apnea: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-06-01

7.  Serum levels of adipocyte fatty acid-binding protein are independently associated with left ventricular mass and myocardial performance index in obstructive sleep apnea syndrome.

Authors:  Mustafa Mücahit Balci; Uğur Arslan; Hikmet Firat; Ibrahim Kocaoğlu; Mustafa Gökhan Vural; Kevser Gülcihan Balci; Orhan Maden; Oğuz Alp Gürbüz; Sadik Ardiç; Ekrem Yeter
Journal:  J Investig Med       Date:  2012-10       Impact factor: 2.895

8.  Tissue kallikrein (kallidinogenase) protects against retinal ischemic damage in mice.

Authors:  Tomomi Masuda; Masamitsu Shimazawa; Fumiya Ishizuka; Shinsuke Nakamura; Kazuhiro Tsuruma; Hideaki Hara
Journal:  Eur J Pharmacol       Date:  2014-05-27       Impact factor: 4.432

9.  Treatment with gelsolin reduces brain inflammation and apoptotic signaling in mice following thermal injury.

Authors:  Qing-Hong Zhang; Qi Chen; Jia-Rui Kang; Chen Liu; Ning Dong; Xiao-Mei Zhu; Zhi-Yong Sheng; Yong-Ming Yao
Journal:  J Neuroinflammation       Date:  2011-09-21       Impact factor: 8.322

10.  Identification of gelsolin, a Ca2+-dependent regulatory protein of actin gel-sol transformation, and its intracellular distribution in a variety of cells and tissues.

Authors:  H L Yin; J H Albrecht; A Fattoum
Journal:  J Cell Biol       Date:  1981-12       Impact factor: 10.539

View more
  3 in total

1.  The relation of severe malocclusion to patients' mental and behavioral disorders, growth, and speech problems.

Authors:  Anu Koskela; Anneli Neittaanmäki; Kaj Rönnberg; Aarno Palotie; Samuli Ripatti; Tuula Palotie
Journal:  Eur J Orthod       Date:  2021-04-03       Impact factor: 3.075

2.  Computational Fluid Dynamics Analysis of Nasal Airway Changes after Treatment with C-Expander.

Authors:  Wang Xiao; Siling Liu; Yanqin Lu; Lei Lei; Ning Liu; Xiaoping Shen; Yuhong He; Ousheng Liu
Journal:  Appl Bionics Biomech       Date:  2021-03-31       Impact factor: 1.781

Review 3.  Rapid Maxillary Expansion (RME): An Otolaryngologic Perspective.

Authors:  Luca Cerritelli; Stavros Hatzopoulos; Andrea Catalano; Chiara Bianchini; Giovanni Cammaroto; Giuseppe Meccariello; Giannicola Iannella; Claudio Vicini; Stefano Pelucchi; Piotr Henryk Skarzynski; Andrea Ciorba
Journal:  J Clin Med       Date:  2022-09-05       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.